The decision may have been made to avoid regulation by the FDA, according to BuzzFeed.
"Advanced biotracking sensors would have made the Apple Watch less of a multipurpose consumer device and more of a medical device used to diagnose diseases or track chronic conditions — which could have opened the watch up to regulation by the U.S. Food and Drug Administration.
'I don’t think Apple wants to be a health-monitoring device maker,' said Harry Wang, director of health and mobile product research at Parks Associates. 'They do want to leverage their popularity on the iPhone as a device platform, integrating all health data that can be collected for different devices.'"
From the article "The Apple Watch Is Scaling Back Its Health Features" by Ian Servantes.
According to the latest U.S. smartphone market share numbers from Parks Associates, Apple is still well in the lead compared to competing manufacturers, holding a beefy 40% of the smartphone market. B...
Unlike seven years ago, the move pushed Netflix’s stock to new heights. The key, for Netflix’s management, was learning to raise prices without spooking subscribers—by doing so in small and infrequent...
“We need to look at problems in the home from a holistic perspective and realize it is the value of all these devices working together that will drive adoption of the smart home,” EVRYTHNG senior vice...
Earlier this year, a report from digital health analyst Parks Associates found that 27 percent of people with a chronic condition want a mobile health device that tracks their health, but a significan...
